KARAMBIOSCIENCE
EST. 2026
EVIDENCE / 02
CRISPR / Research & discoveryOverviewTarget evidenceProgramsWork with KaramMethodsSources
A cinematic molecular-and-climate scene with a CRISPR complex, cells and a planet.
CRISPR Atlas / External evidence
Animals + human association

Aged T-cell function: the intervention direction matters

Screens identified Dusp5 and Zfp219 as regulators of T-cell expansion or cytotoxic function. Zfp219 loss combined with checkpoint inhibition improved tumor control in aged mice; the human ZNF219 observations were associative.

Compare in the Atlas
Concept illustration / not experimental evidence

What was reported

Screens identified Dusp5 and Zfp219 as regulators of T-cell expansion or cytotoxic function. Zfp219 loss combined with checkpoint inhibition improved tumor control in aged mice; the human ZNF219 observations were associative. [C02]

What the result does not establish

Mouse tumor control is not proof of general human immune rejuvenation. Dusp5, Zfp219 and human ZNF219 cannot be used interchangeably.

Measured endpoint

T-cell expansion, cytotoxic function and mouse tumor control.

Karam’s next question

Which immune function changes, in which model, and can an independent specialist reproduce the result?

Assessment-derived brief. Cited in the supplied 15 October 2026 project assessment; not independently reviewed in this website release. Karam has not reproduced the experiment or independently audited the underlying dataset. This is not Karam-generated evidence.

Record transparency

The details—and the missing values.

Extraction scope: supplied project assessment, not an independent full-methods extraction
Study date2026-07-29
Reported regionUnited States
Species / biological systemMouse; human association
Target / subjectDusp5 / Zfp219; human ZNF219
Cell or population contextT cells in an aged tumor environment
Perturbation directionLoss of function; combination with checkpoint inhibition
MethodCas9 screen
Delivery settingExperimental immune-cell perturbation
ComparatorNot extracted in the supplied assessment; review the primary source before using this field.
Donor contextNot extracted in the supplied assessment; review the primary source before using this field.
Sample size / unitNot extracted in the supplied assessment; review the primary source before using this field.
Follow-upNot extracted in the supplied assessment; review the primary source before using this field.
Safety measurementsNot extracted in the supplied assessment; review the primary source before using this field.
Independent replicationNot established in the supplied assessment
Data accessNot extracted in the supplied assessment; review the primary source before using this field.

What would this evidence change?

Use the context in this record to define a bounded research or diligence question. A cited finding is not a validated Karam asset.

Discuss a scopeExplore the Atlas